Terns Pharmaceuticals Balance Sheet (2020-2025) | TERN

Balance Sheet Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)
98.83M67.59M64.75M47.70M43.88M16.81M62.98M23.03M169.41M80.92M37.89M79.93M65.10M91.50M148.24M161.44M110.31M145.97M126.59M500.79M
Short-term Investments (Quarter)
96.75M117.50M112.44M118.28M107.39M123.00M124.31M139.88M113.17M204.68M228.71M183.51M175.56M133.80M102.64M196.72M195.24M169.48M144.94M494.24M
Cash & Current Investments (Quarter)
195.58M185.08M177.20M165.98M151.27M139.81M187.29M162.91M282.58M285.60M266.60M263.44M240.65M225.30M250.88M358.16M305.55M315.44M271.53M995.02M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)
2.46M1.79M1.60M0.95M2.84M2.79M3.25M2.07M2.14M2.71M3.85M3.99M5.24M4.94M3.73M3.94M3.48M3.51M4.66M5.21M
Current Assets (Quarter)
198.04M186.87M178.79M166.93M154.11M142.60M190.54M285.19M299.66M288.31M270.45M267.43M245.90M230.24M376.51M362.11M337.75M318.95M300.30M1,024.19M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
1.02M0.96M0.93M1.05M1.11M0.95M0.81M0.76M0.68M0.59M0.53M0.51M0.45M0.37M0.29M0.22M0.08M0.07M0.06M0.05M
Other Non-Current Assets (Quarter)
0.17M0.18M0.17M0.09M0.07M0.06M0.05M0.04M0.04M0.04M0.04M0.06M0.06M0.06M0.06M0.35M0.35M0.36M0.36M
Non-Current Assets (Quarter)
1.20M1.14M1.10M1.14M2.56M2.26M2.05M1.84M1.62M1.38M1.23M1.08M0.87M0.64M1.73M1.82M1.57M1.46M1.36M0.88M
Assets (Quarter)
199.24M188.01M179.89M168.07M156.67M144.86M192.59M287.03M301.29M289.70M271.69M268.52M246.77M230.88M378.23M363.93M339.31M320.42M301.65M1,025.08M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
4.25M1.69M1.58M2.13M1.68M0.97M2.09M1.65M2.69M5.54M3.33M2.52M1.70M1.87M1.79M2.15M2.78M2.85M2.95M1.72M
Payables (Quarter)
4.25M1.69M1.58M2.13M1.68M0.97M2.09M1.65M2.69M5.54M3.33M2.52M1.70M1.87M1.79M2.15M2.78M2.85M2.95M1.72M
Accumulated Expenses (Quarter)
4.13M0.95M5.31M4.69M3.90M4.49M4.72M3.84M8.76M8.05M8.05M8.83M6.70M8.83M9.35M13.07M7.73M9.62M11.98M14.22M
Other Accumulated Expenses (Quarter)
0.08M0.13M0.08M0.36M0.27M0.15M0.31M0.18M0.36M0.28M0.39M0.28M0.53M0.32M0.48M0.46M0.58M0.46M0.94M0.45M
Short term Debt (Quarter)
Current Leases (Quarter)
0.58M0.59M0.67M0.66M0.66M0.65M0.71M0.60M0.43M0.25M0.27M0.43M0.43M0.44M0.46M0.47M
Total Current Liabilities (Quarter)
8.38M5.82M6.89M6.82M6.17M6.04M7.48M8.47M12.11M14.24M12.09M11.94M8.83M10.96M11.41M15.65M10.94M12.91M15.39M16.41M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
0.21M0.19M0.18M0.16M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
1.00M0.85M0.70M0.54M0.39M0.22M0.06M1.03M0.92M0.81M1.13M0.57M0.45M
Other Non-Current Liabilities (Quarter)
0.65M0.66M0.67M0.79M0.79M0.75M0.71M1.07M1.11M1.09M1.11M1.21M1.22M1.24M1.32M1.49M1.53M1.58M1.63M1.70M
Total Non-Current Liabilities (Quarter)
8.59M6.01M7.07M6.98M7.17M6.89M8.18M9.01M12.49M14.46M12.15M11.94M8.83M10.96M12.45M16.57M11.74M13.60M15.96M16.86M
Total Liabilities (Quarter)
9.24M6.67M7.73M7.77M7.95M7.64M8.89M10.08M13.60M15.55M13.26M13.15M10.05M12.20M13.76M18.06M13.27M15.19M17.59M18.55M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)
190.00M181.33M172.16M160.30M148.72M137.22M183.69M276.94M287.68M274.15M258.43M255.37M236.72M218.68M364.47M345.87M326.04M305.23M284.07M1,006.52M
Shareholder's Equity (Quarter)
190.00M181.33M172.16M160.30M148.72M137.22M183.69M276.94M287.68M274.15M258.43M255.37M236.72M218.68M364.47M345.87M326.04M305.23M284.07M1,006.52M
Liabilities and Shareholders Equity (Quarter)
199.24M188.01M179.89M168.07M156.67M144.86M192.59M287.03M301.29M289.70M271.69M268.52M246.77M230.88M378.23M363.93M339.31M320.42M301.65M1,025.08M
Retained Earnings (Quarter)
-0.23M-0.17M-167.82M-182.07M-0.90M-209.78M-226.60M-242.42M-263.95M-0.78M-311.61M-332.63M-0.32M-0.44M0.16M-421.48M-445.39M-469.48M-494.12M-517.69M
Treasury Shares (Quarter)
0.07M0.07M0.10M0.10M0.13M0.39M0.37M0.36M0.37M0.92M0.78M0.58M0.55M0.65M0.61M0.53M0.48M